Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Ergo Science Corporation

Ergo Science Corporation is developing the drug ERGOSET(R) tablets for the treatment of metabolic disorders.


Contact Details:
790 Turnpike Street
North Andover
MA
01845
United States of America
Tel:978 974 9474
Fax:
Email:
WWW:

www.ergo.com/




Loading...

Recent Publications by Ergo Science Corporation:

Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster.
Bromocriptine, a dopamine D2 agonist, inhibits seasonal fattening and...
17th June, 2000
Ergo Science Corporation, North Andover, Massachusetts, USA. Chronobiol Int. 2000 Mar;17(2):155-72.
Chronic ventromedial hypothalamic infusion of norepinephrine and serotonin promotes insulin resistance and glucose intolerance.
The ventromedial hypothalamus (VMH) is involved in the regulation of...
25th April, 2000
Ergo Science Neuroendocrinology. 1999 Dec;70(6):460-5.
Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice.
Hypothalamic neuropeptide Y (NPY) and corticotropin-releasing hormone...
25th April, 2000
Ergo Science Corporation, N. Andover, Mass., USA. Neuroendocrinology. 2000 Jan;71(1):68-78.
Hyperinsulinemia increases norepinephrine metabolism in the ventromedial hypothalamus of rats.
Numerous studies have implicated increased ventromedial hypothalamic (VMH)...
4th March, 2000
Ergo Science Corp., North Andover, MA 01845, USA. Neuroreport. 2000 Feb 7;11(2):383-7.

Ergo Science Corporation Patents:

US Patent No.Title
5905083 Method of treating rheumatoid arthritis
5554623 Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates
5565454 Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
5585347 Methods for the determination and adjustment of prolactin daily rhythms
5626860 Method for regulating metabolism with dopamine beta hydroxylase inhibitors

View more Ergo Science Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 470 times since April 2007, the link to the organisation's website has been followed 77 times

Recent Search Terms used to find this page: ergo science corporation | ergo science corporation | Ergo Science | ergo science corporatioN 2009 | Ergo Science Corporation north andover | Ergo Science Corporation is developing the drug ERGOSET(R) tablets for the treatment of metabolic disorders. | Ergo Science Corporation is developing the drug ERGOSET(R) tablets for the treatment of metabolic disorders. | Ergo Science Corp. North Andover MA | .

Search for more companies in North Andover

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ergo Science Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.